Antifungals used in Visual Snow Syndrome may modulate neuroinflammatory processes and potentially impact microglial activation, which could contribute to neurological symptom regulation. These medications, such as fluconazole or itraconazole, may exert neuroprotective effects through inhibition of inflammatory pathways and potential mitigation of neuronal hyperexcitability associated with the syndrome.